HEADER APOPTOSIS 05-SEP-23 8U27 TITLE BCL-2-XL COMPLEXED WITH COMPOUND 35 COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOPTOSIS REGULATOR BCL-2, BCL-2-LIKE PROTEIN 1 CHIMERA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BCL2-L-1,APOPTOSIS REGULATOR BCL-X; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BCL2, BCL2L1, BCL2L, BCLX; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS AUTOPHAGY, APOPTOSIS, SELECTIVE INHIBITION EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR J.RIZO,Y.-Z.PAN REVDAT 3 15-MAY-24 8U27 1 REMARK REVDAT 2 08-NOV-23 8U27 1 JRNL REVDAT 1 13-SEP-23 8U27 0 JRNL AUTH Y.Z.PAN,Q.LIANG,D.R.TOMCHICK,J.K.DE BRABANDER,J.RIZO JRNL TITL STRUCTURAL INSIGHTS FOR SELECTIVE DISRUPTION OF BECLIN 1 JRNL TITL 2 BINDING TO BCL-2. JRNL REF COMMUN BIOL V. 6 1080 2023 JRNL REFN ESSN 2399-3642 JRNL PMID 37875561 JRNL DOI 10.1038/S42003-023-05467-W REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8U27 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1000277029. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 293; 293; 293 REMARK 210 PH : 7.3; 7.3; 7.3 REMARK 210 IONIC STRENGTH : 0.0375; 0.0375; 0.0375 REMARK 210 PRESSURE : 1 ATM; 1 ATM; 1 ATM REMARK 210 SAMPLE CONTENTS : 300 UM [U-99% 13C; U-99% 15N] REMARK 210 BCL-2-XL, 300 UM COMPOUND 35, 93% REMARK 210 H2O/7% D2O; 300 UM [U-99% 15N] REMARK 210 BCL-2-XL, 300 UM COMPOUND 35, REMARK 210 100% D2O; 300 UM [U-10% 13C] BCL- REMARK 210 2-XL, 300 UM COMPOUND 35, 93% REMARK 210 H2O/7% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCO; 3D REMARK 210 HNCACB; 3D CBCA(CO)NH; 3D HCCH- REMARK 210 TOCSY; 3D C(CO)NH; 3D H(CCO)NH; REMARK 210 2D 1H-1H NOESY; 2D 1H-1H TOCSY; REMARK 210 2D HBCBCGCDHD; 2D HBCBCGCDCEHE; REMARK 210 15N,13C-15N,13C-FILTERED REMARK 210 HOMONUCLEAR 2D TOCSY; 15N,13C- REMARK 210 15N,13C-FILTERED HOMONUCLEAR 2D REMARK 210 NOESY; SIMULTANEOUS 3D 1H-15N, REMARK 210 1H-13C NOESY-HSQC; CONSTANT-TIME REMARK 210 1H-13C HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : DDX REMARK 210 SPECTROMETER MANUFACTURER : AGILENT REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : VNMRJ 4.2 REVISION A, NMRPIPE, REMARK 210 NMRVIEWJ, CNS 1.2 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 4497 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 4 102.34 60.03 REMARK 500 1 GLU A 38 30.43 -158.30 REMARK 500 1 GLU A 42 43.28 -95.80 REMARK 500 1 LEU A 78 109.61 -52.72 REMARK 500 1 MET A 165 96.66 -58.45 REMARK 500 1 PRO A 167 96.68 -45.07 REMARK 500 1 PHE A 169 154.05 -45.12 REMARK 500 1 SER A 175 107.85 -56.51 REMARK 500 2 ALA A 2 101.38 -161.17 REMARK 500 2 ARG A 6 145.31 62.68 REMARK 500 2 THR A 7 75.04 53.54 REMARK 500 2 TYR A 9 175.78 -59.52 REMARK 500 2 ASP A 34 102.15 -45.68 REMARK 500 2 ASN A 39 19.98 58.10 REMARK 500 2 PRO A 44 88.73 -67.90 REMARK 500 2 MET A 165 109.28 -56.02 REMARK 500 2 LEU A 168 39.71 -142.72 REMARK 500 3 ALA A 2 117.79 -175.13 REMARK 500 3 ASP A 31 78.45 -112.74 REMARK 500 3 GLU A 38 -164.65 -172.95 REMARK 500 3 PRO A 44 81.03 -69.56 REMARK 500 3 MET A 165 99.80 -58.13 REMARK 500 3 PRO A 167 94.15 -46.97 REMARK 500 4 ALA A 2 -51.92 -128.26 REMARK 500 4 THR A 7 -173.25 55.48 REMARK 500 4 TYR A 9 106.49 -59.77 REMARK 500 4 ASP A 31 76.94 -116.49 REMARK 500 4 GLU A 42 79.78 -101.67 REMARK 500 4 PRO A 44 81.79 -67.88 REMARK 500 4 GLU A 45 44.81 -94.78 REMARK 500 4 MET A 165 108.42 -58.84 REMARK 500 4 LEU A 168 39.65 -147.46 REMARK 500 5 ASP A 35 95.15 -53.07 REMARK 500 5 GLU A 42 52.16 -90.41 REMARK 500 5 PRO A 44 88.81 -53.41 REMARK 500 5 MET A 165 94.89 -59.38 REMARK 500 5 PRO A 167 95.18 -46.04 REMARK 500 6 HIS A 3 39.92 -141.09 REMARK 500 6 GLU A 38 -161.49 -178.00 REMARK 500 6 PRO A 44 83.03 -67.33 REMARK 500 6 MET A 165 107.90 -58.23 REMARK 500 6 PRO A 167 91.30 -54.63 REMARK 500 6 LEU A 168 39.57 -141.19 REMARK 500 7 ARG A 6 -170.70 46.80 REMARK 500 7 ASP A 31 79.23 -113.90 REMARK 500 7 GLU A 37 36.59 38.84 REMARK 500 7 GLU A 38 75.91 55.77 REMARK 500 7 ASN A 39 -46.91 -146.05 REMARK 500 7 PRO A 44 79.81 -68.72 REMARK 500 7 GLU A 124 37.66 77.84 REMARK 500 REMARK 500 THIS ENTRY HAS 184 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 52100 RELATED DB: BMRB DBREF 8U27 A 1 34 UNP P10415 BCL2_HUMAN 1 34 DBREF 8U27 A 35 50 UNP Q07817 B2CL1_HUMAN 29 44 DBREF 8U27 A 51 177 UNP P10415 BCL2_HUMAN 92 218 SEQRES 1 A 177 MET ALA HIS ALA GLY ARG THR GLY TYR ASP ASN ARG GLU SEQRES 2 A 177 ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SER GLN ARG SEQRES 3 A 177 GLY TYR GLU TRP ASP ALA GLY ASP ASP VAL GLU GLU ASN SEQRES 4 A 177 ARG THR GLU ALA PRO GLU GLY THR GLU SER GLU VAL VAL SEQRES 5 A 177 HIS LEU THR LEU ARG GLN ALA GLY ASP ASP PHE SER ARG SEQRES 6 A 177 ARG TYR ARG ARG ASP PHE ALA GLU MET SER SER GLN LEU SEQRES 7 A 177 HIS LEU THR PRO PHE THR ALA ARG GLY ARG PHE ALA THR SEQRES 8 A 177 VAL VAL GLU GLU LEU PHE ARG ASP GLY VAL ASN TRP GLY SEQRES 9 A 177 ARG ILE VAL ALA PHE PHE GLU PHE GLY GLY VAL MET CYS SEQRES 10 A 177 VAL GLU SER VAL ASN ARG GLU MET SER PRO LEU VAL ASP SEQRES 11 A 177 ASN ILE ALA LEU TRP MET THR GLU TYR LEU ASN ARG HIS SEQRES 12 A 177 LEU HIS THR TRP ILE GLN ASP ASN GLY GLY TRP ASP ALA SEQRES 13 A 177 PHE VAL GLU LEU TYR GLY PRO SER MET ARG PRO LEU PHE SEQRES 14 A 177 ASP PHE SER TRP LEU SER LEU LYS HET ULL A 201 57 HETNAM ULL PROPAN-2-YL {4-[(5S)-1-(4-BROMOBENZOYL)-5-PHENYL-4,5- HETNAM 2 ULL DIHYDRO-1H-PYRAZOL-3-YL]PHENYL}CARBAMATE FORMUL 2 ULL C26 H24 BR N3 O3 HELIX 1 AA1 ASP A 10 ARG A 26 1 17 HELIX 2 AA2 GLY A 46 TYR A 67 1 22 HELIX 3 AA3 TYR A 67 LEU A 78 1 12 HELIX 4 AA4 THR A 84 PHE A 97 1 14 HELIX 5 AA5 ASN A 102 ARG A 123 1 22 HELIX 6 AA6 MET A 125 HIS A 143 1 19 HELIX 7 AA7 HIS A 143 ASN A 151 1 9 HELIX 8 AA8 GLY A 152 TYR A 161 1 10 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1